Using capsule endoscopy instead of colonoscopy for colonic disease

Capsule Endoscopy as an Alternative to Colonoscopy. Could the Number of Colonoscopies be Reduced?

NA · Hospital Clinic of Barcelona · NCT06031051

This study is testing if using a small camera capsule instead of a regular colonoscopy can help figure out which patients really need the colonoscopy, making the process easier and more efficient for everyone.

Quick facts

PhaseNA
Study typeInterventional
Enrollment704 (estimated)
Ages18 Years and up
SexAll
SponsorHospital Clinic of Barcelona (other)
Locations4 sites (Santa Cruz De Tenerife, Canarias and 3 other locations)
Trial IDNCT06031051 on ClinicalTrials.gov

What this trial studies

This prospective, multicenter interventional study evaluates the effectiveness of capsule endoscopy (CE) as an alternative to traditional colonoscopy in patients scheduled for non-urgent colonoscopy. Patients will undergo CE to identify those who may not need a colonoscopy, thereby reducing unnecessary procedures and prioritizing patients who require endoscopic intervention. If CE results are negative, patients will proceed with their scheduled colonoscopy; if positive, a colonoscopy will be performed within 30 days. The study aims to improve patient management and optimize endoscopy resources.

Who should consider this trial

Good fit: Ideal candidates include patients with iron deficiency anemia, rectal bleeding, chronic gastrointestinal symptoms, or suspected colorectal cancer who are scheduled for a non-urgent colonoscopy.

Not a fit: Patients with complicated acute diverticulitis, positive FIT results, or contraindications to capsule endoscopy will not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could reduce the number of unnecessary colonoscopies and improve patient prioritization for endoscopic procedures.

How similar studies have performed: Other studies have shown promise in using capsule endoscopy for similar purposes, indicating potential for success in this approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Iron deficiency anaemia with or without a colonoscopy performed within the last 5 years

  * Rectal bleeding/haematochezia in patients \>50 years who have undergone a colonoscopy \<5 years ago or \<50 years with no risk factors for CRC
  * Chronic constipation/abdominal distension/abdominal pain/diarrhea
  * Suspected CRC due to clinical criteria (NICE guidelines 2015, updated in 2017) with no iFOBT performed
  * Recent change in bowel habits
  * Follow-ups: post-polypectomy syndrome, family history of CRC, hereditary syndromes, CRC surgery, Inflammatory Bowel Disease

Exclusion Criteria:

* Study following an episode of complicated acute diverticulitis or with an uncertain diagnosis of acute diverticulitis
* Evaluation following fragmented resection (recurrence ruled out)
* Patients with a positive FIT
* Pregnancy or breast-feeding
* Any contraindication to Crohn's Capsule endoscopy such as known or suspected gastrointestinal obstruction, strictures or fistulas, a previous altered Patency capsule, dysphagia or other swallowing disorders and cardiac pacemakers or other implanted electromedical devices.
* Allergy or known contraindication to the medications and preparations agents used in the procedure.

Where this trial is running

Santa Cruz De Tenerife, Canarias and 3 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Colonic Disease

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.